Scientific method

SIT Rolos opens its Machine Intelligence Platform to academia and business to accelerate the research

Retrieved on: 
Tuesday, October 18, 2022
Cloud, Data management, Robotics, Computation, Software as a service, MI, Central processing unit, National university, Research, SIT, CPU, Professional sports, National University of Singapore, Software, Data science, HPC, Business analytics, Rolo, Scientific method, Central, CEST, GLOBE, GPU, Physics, Running, Big data, Platform, Video game console

SCHAFFHAUSEN, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- SIT Rolos announced today that it would bring research to a new level by opening its Machine Intelligence (MI) Platform to all scientific groups.

Key Points: 
  • SCHAFFHAUSEN, Switzerland, Oct. 18, 2022 (GLOBE NEWSWIRE) -- SIT Rolos announced today that it would bring research to a new level by opening its Machine Intelligence (MI) Platform to all scientific groups.
  • Any researcher from academia or business can now configure, run and collaborate with others on their computational research project through Rolos Platform.
  • Rolos Platform addresses two major problems in research: infrastructure setup and teamwork.
  • SIT Rolos provides a Machine Intelligence Platform with consulting and applications for academia and business.

GI OnDEMAND Partnership with Mindset Health/Nerva Makes It Easy for Gastroenterology Practices Nationwide to Deliver Gut-Directed Hypnotherapy to Their IBS Patients

Retrieved on: 
Thursday, October 20, 2022
Genetic counseling, Education, Therapy, American College of Gastroenterology, Diagnosis, THE, OnDemand, Patient, Doctor of Psychology, Scientific method, Program, Mindset Network, GI, Charlotte Convention Center, Partnership, University, FUTURE, IBS, ACG, Irritable bowel syndrome, Health, Practice management software, Department, Founder, College, Gold, Overalls, Genetic testing, American College, Monash, FODMAP, Monash University, Health care, Medical device, Medicine, Gastroenterology

GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., now provides GI OnDEMAND and ACG members nationwide an evidence-based program to deliver gut-directed hypnotherapy to their IBS patients.

Key Points: 
  • GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., now provides GI OnDEMAND and ACG members nationwide an evidence-based program to deliver gut-directed hypnotherapy to their IBS patients.
  • Nerva is a self-directed digital therapeutic with proven benefits that patients will find easy to use and effective."
  • I look forward to working tirelessly with GI OnDEMAND to enable the widespread use of Nerva to some 1 billion + IBS sufferers worldwide."
  • Partnering with Dr. Simone Peters, Nerva was created to increase access to one of the most effective options for IBS patients; gut-directed hypnotherapy.

2CRSi, Clever Cloud, Kalray and Vates Join Forces for Sovereign and Innovative Data Center Equipment

Retrieved on: 
Monday, October 17, 2022
Software, Mobile, Wireless, Internet, Professional Services, Hardware, Data Management, Apps, Applications, Technology, Other Manufacturing, Other Professional Services, Other Technology, Manufacturing, Reverse, Automotive industry, Efficiency, DPU, Euronext Growth, Architecture, SNCF, Euronext Paris, Platform as a service, Entertainment, Renault–Nissan–Mitsubishi Alliance, CEA, Data, NXP Semiconductors, Technology, Data management, AXA, Automation, ISIN, Software, Scientific method, Industry, AMI, AI, Xen, Founder, CEO, Ecosystem, Edge computing, List of life sciences, Citrix Systems, NXP, Solution, Video game console, Cryptocurrency, Euronext, MAIF, Group, European, Kalray, Airbus, Cloud

New classes of equipment are needed based on new hardware and software foundations to provide more efficient, power-optimized, and more open data center infrastructures.

Key Points: 
  • New classes of equipment are needed based on new hardware and software foundations to provide more efficient, power-optimized, and more open data center infrastructures.
  • The ReNESENS project is bringing together some of the most advanced French companies with unique expertise in the new class of DPU data processors, virtualization software, highly efficient servers and innovative data center architecture; Vates, Clever Cloud, Kalray and 2CRSi.
  • The project intends to develop an innovative and attractive sovereign proposition, for both end users and the ecosystem of data center players.
  • Clever Cloud will bring all its expertise to this initiative and to its partners 2CRSi, Kalray and Vates.

GI OnDEMAND Announces Partnership with Trellus Health Enabling Gastroenterology Practices Nationwide to Provide Coordinated and Personalized Psychosocial and Nutritional Support for all Patients with IBD

Retrieved on: 
Wednesday, October 19, 2022
Genetic counseling, Inflammatory bowel disease, Education, Mount Sinai Health System, Disease, American College of Gastroenterology, Diagnosis, Crohn's disease, OnDemand, Patient, Gastroenterology, Scientific method, Program, Entrepreneurship, FACG, Mental health, GI, Charlotte Convention Center, Partnership, Technology, University, Emergency department, Company, ACG, MD, Doctor of Philosophy, Health, Practice management software, CEO, IBD, LSE, Awareness, College, Face, Genetic testing, Self-management, Ulcerative colitis, A&E, American College, Conditional sentence, Health care, Pharmaceutical industry, Medicine, Management

GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer access to the Trellus scientifically validated resilience training and self-management programs, to all GI OnDEMAND and ACG members nationwide.

Key Points: 
  • GI OnDEMAND, a joint venture between the American College of Gastroenterology and Gastro Girl, Inc., will now offer access to the Trellus scientifically validated resilience training and self-management programs, to all GI OnDEMAND and ACG members nationwide.
  • At Trellus we hope to empower patients to master the art of self-management, manage their IBD with confidence, and improve health outcomes at a significantly lower cost."
  • "GI OnDEMAND expands a provider's ability to deliver a first in class patient self-management solution for IBD.
  • Gastro Girl and ACG expanded this partnership in 2019 to make digestive health expertise, resources and support available to everyone via GI OnDEMAND.

HUAWEI CONNECT 2022 in Dubai: Innovative Infrastructure Drives Industrial Digital Transformation

Retrieved on: 
Thursday, October 13, 2022
CONNECT, Cloud, HUAWEI, Trust, Education, Ministry of Higher Education and Scientific Research (UAE), HALP, Organization, Commvault, Research, ICT, Program, Data, Technology, Data management, Ministry of higher education, Industry, Scientific method, AI, United Arab Emirates, Ecosystem, Ministry, Rotation, CIO, Galaxy, Digital, Institute for Studies in Industrial Development, CERN openlab, SME, Mobile phone, Network equipment, Huawei

Representatives from Egypt's Ministry of Higher Education and Scientific Research, Nigeria's Galaxy Backbone Limited, Huawei, and other organizations shared their latest digitalization practices, exploring new paths to industrial digital transformation.

Key Points: 
  • Representatives from Egypt's Ministry of Higher Education and Scientific Research, Nigeria's Galaxy Backbone Limited, Huawei, and other organizations shared their latest digitalization practices, exploring new paths to industrial digital transformation.
  • Build out local digital ecosystems including partner development, strengthening the digital talent pool, and providing more support for SMEs.
  • Together, they work to build a solid digital foundation for all and reinforce local digital ecosystems to support the future of digital nations.
  • He explained in his keynote speech "Innovative Digital Infrastructure Accelerates Digital Transformation" that "Data is at the core of digital transformation, and data ingestion, transmission, storage, and analysis are key steps.

Numinus Develops Mushroom Tea for Use in Psychedelic Research

Retrieved on: 
Wednesday, October 5, 2022
Government, Professional, Growth, TSX, Policy, Patient, Perception, Depression, Research, Health Canada, Company, Acquisition, Palliative care, Scientific method, Industry, Market Access Program, Trauma, Pain, Innovation, Anxiety, Forward-looking statement, COVID-19, Public opinion, Health, Risk, Special access program, Pharmaceutical industry, List of cosmic entities in Marvel Comics, Psilocybe

"The Numinus team has developed the Psilocybe tea bag with scientific precision in mind," said Sharan Sidhu, Numinus VP, Scientific Research, Innovation & Laboratory Operations.

Key Points: 
  • "The Numinus team has developed the Psilocybe tea bag with scientific precision in mind," said Sharan Sidhu, Numinus VP, Scientific Research, Innovation & Laboratory Operations.
  • The research behind the tea bag involved the development of processes and procedures to deliver 25mg per dose and the use of Numinus' validated strains of Psilocybe cubensis.
  • The tea bag will be studied in a phase 1 trial of practitioners receiving experiential training for psilocybin-assisted therapy, with the goal to be used in Numinus' research, including trial partnerships at Cedar Clinical Research, Numinus' clinical trial management division.
  • The Numinus model - including psychedelic production, research and clinic care - is at the forefront of a transformation aimed at healing rather than managing symptoms for depression, anxiety, trauma, pain and substance use.

Global Remote Sensing Services Market Research Report to 2027 - Featuring Harris Geospatial Solutions, Lockheed Martin, Mallon Technology and Northrop Grumman Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, September 23, 2022
Technology, Hardware, Customer support, COVID-19, Oil, Energy, Scientific method, Acquisition, Growth, USD, Investment, Certification, Decision-making, Strategic management, Milltown Biomass-to-Energy Power Station, Use, Value, R, Business Growth Fund, Market share analysis, CAGR, Retail, Agriculture

What are the inhibiting factors and impact of COVID-19 shaping the Global Remote Sensing Services Market during the forecast period?

Key Points: 
  • What are the inhibiting factors and impact of COVID-19 shaping the Global Remote Sensing Services Market during the forecast period?
  • Which are the products/segments/applications/areas to invest in over the forecast period in the Global Remote Sensing Services Market?
  • What is the market share of the leading vendors in the Global Remote Sensing Services Market?
  • What modes and strategic moves are considered suitable for entering the Global Remote Sensing Services Market?

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Retrieved on: 
Wednesday, September 14, 2022
Institute, Degenerative disease, Central nervous system, Neurodegeneration, University of Bordeaux 1, Autophagy, CNRS, AAV, MD, MSA, French National Centre for Scientific Research, Phenotype, Coronavirus Scientific Advisory Board (Turkey), Scientific method, IND, Parkinson's disease, Re Recher's Will Trusts, Partnership, National Centre for Disease Control, Therapy, INSERM, EB, CEO, TFEB, SAB, Multiple system atrophy, CNS, Eye, University, PD, IMN, Pharmaceutical industry, Vaccine, Medical device, Wood drying, Genetics, Idinvest Partners, Medicine

Overexpression of TFEB via gene therapy demonstrates potential to reduce and prevent the accumulation of toxic protein aggregates1 and to consequently prevent neurodegeneration.

Key Points: 
  • Overexpression of TFEB via gene therapy demonstrates potential to reduce and prevent the accumulation of toxic protein aggregates1 and to consequently prevent neurodegeneration.
  • We look forward to leveraging our collective strengths to best develop gene therapy programs for neurodegenerative diseases with the potential to improve patient outcomes."
  • "We are delighted to be collaborating with IMN to develop coAAVs carrying TFEB and explore these gene therapy constructs for the treatment of neurodegenerative diseases.
  • Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and eye diseases.

Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders

Retrieved on: 
Wednesday, September 14, 2022
Institute, Degenerative disease, Central nervous system, Neurodegeneration, University of Bordeaux 1, Autophagy, CNRS, AAV, MD, MSA, French National Centre for Scientific Research, Phenotype, Coronavirus Scientific Advisory Board (Turkey), Scientific method, IND, Parkinson's disease, Re Recher's Will Trusts, Partnership, National Centre for Disease Control, Therapy, INSERM, EB, CEO, TFEB, SAB, Multiple system atrophy, CNS, Eye, University, PD, IMN, Pharmaceutical industry, Vaccine, Medical device, Wood drying, Genetics, Idinvest Partners, Medicine

Overexpression of TFEB via gene therapy demonstrates potential to reduce and prevent the accumulation of toxic protein aggregates1 and to consequently prevent neurodegeneration.

Key Points: 
  • Overexpression of TFEB via gene therapy demonstrates potential to reduce and prevent the accumulation of toxic protein aggregates1 and to consequently prevent neurodegeneration.
  • We look forward to leveraging our collective strengths to best develop gene therapy programs for neurodegenerative diseases with the potential to improve patient outcomes."
  • "We are delighted to be collaborating with IMN to develop coAAVs carrying TFEB and explore these gene therapy constructs for the treatment of neurodegenerative diseases.
  • Coave Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for CNS (Central Nervous System) and eye diseases.

Next Generation Biologics Market Report 2022: Rising Demand for ADCs, Technological Advancements & Growing Reimbursement Support Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Friday, September 9, 2022
Health, Pharmaceutical, Antibody, Regenerative medicine, Failure, Scientific method, Insulin, Region, USD, Control, CAGR, Pharmaceutical industry

The "Next Generation Biologics Market Analysis by Type (Regenerative Medicine, Antibodies, Insulin, Growth Hormones), by Application (Scientific Research, Medical), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Next Generation Biologics Market Analysis by Type (Regenerative Medicine, Antibodies, Insulin, Growth Hormones), by Application (Scientific Research, Medical), and by Region - Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The global market size for next generation biologics products is estimated to be USD 5,981.6 million in 2021 and is expected to witness a CAGR of 8.85% during the forecast period.
  • Rising demand for ADCs, technological advancements, growing reimbursement support, and escalating investment in R&D are the major factors driving the global next generation biologics market.
  • However, various factors such as complexities in manufacturing of biologics, complicated regulatory framework, and difficulties in patient recruitment for conducting clinical trials, high cost, and failure rate in clinical trials are hindering the market growth.